Navigation Links
Hotspur Technologies Commences US Launch at Veith/AIM Conference in New York City
Date:11/16/2011

NEW YORK, Nov. 16, 2011 /PRNewswire/ -- Hotspur Technologies today announced the launch of the company's GPSCath™ Balloon Dilatation Catheter in the United States and select international markets.  The company made the announcement today.  

Hotspur's innovative GPSCath™ Balloon Dilatation Catheter integrates a proprietary valve into a balloon catheter, allowing physicians to inject contrast during a procedure without the need for removal of the balloon catheter or adjustment of guidewire position.  Combining these multiple functions into one device can potentially reduce the time and expense required to complete peripheral angioplasty procedures, allowing physicians to work more efficiently.

To support this initial launch, Hotspur has entered into exclusive distribution agreements with SurgPro, LLC, and TD Medical, leading medical device distributors in the interventional radiology space for the southeastern United States and the Netherlands, respectively.  While these regions are the initial focus of Hotspur's launch, the company will continue to expand its distribution network throughout the United States and other select international markets in 2012.

"My use of the GPSCath™ has been a highly positive experience, and I look forward to using more of these devices in the future as well as seeing what other innovations Hotspur will bring to the market," said Dr. Tom DiBartholomeo, an interventional radiologist and early adopter of the product.

During the company's recently completed limited market launch, over 150 GPSCath™ balloon catheters were successfully used in more than 100 dialysis access procedures.  This initial product experience validated the performance of both the angioplasty and injection functions of the GPSCath™, while also reinforcing the benefit of combining the multiple functions into one unique catheter.  

"I am very excited about the launch of GPSCath™.  We have been very impressed with the device performance, and we feel that the GPSCath™ will make a significant impact in providing better care for patients and reducing procedure times for physicians," said Gwen Watanabe, President & CEO of Hotspur Technologies. "In the near future, I am also looking forward to launching a number of new novel products in the US market, which will underscore the strength of the company's pipeline and the depth of our R&D."

About Hotspur Technologies

Founded in 2008 and located in Mountain View, California, Hotspur Technologies (www.hotspur-inc.com) is a leading developer of catheter-based technologies aimed at restoring blood flow for patients with obstructed vessels.  The company's products are based on a unique technology that opens blood vessels more efficiently and less invasively. The firm's VisioValve™ technology serves as a launching point to improve patient outcome and physician efficiency. Hotspur is privately held.  Its investors include ONSET Ventures, Finistere Ventures, BioStar Ventures, Saratoga Ventures, Millennium Life Sciences Ventures, Incept, and Versant Ventures.

CONTACT: Will Martin, (770) 639-2777, will@hotspur-inc.com


'/>"/>
SOURCE Hotspur Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hotspur Technologys Novel 3-in-1 Angioplasty Balloon Successfully Achieves First Commercial Deployment
2. Hotspur Technologies Continues to Bring Innovations to Peripheral Vascular Market
3. First Hotspur Peripheral Angioplasty Case Completed
4. Hotspurs Keeper Embolectomy Catheter Deployed for First Time
5. Hotspur Technologies’ IQCath Catheter Receives CE Mark
6. Hotspur Technologies Appoints Fred Khosravi Chairman of the Board
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
11. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016 According to a ... by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical ... Nephrology, Infectious Diseases) - Forecast to 2021" published ... USD 60.22 Billion in 2016. This market is ... during the forecast period (2016-2021) to reach USD ...
(Date:12/2/2016)...  The Addiction Treatment Advisory Group (ATAG), created ... Pharmacy (AMCP), has released detailed findings on how ... addiction crisis, including through improved access to naloxone ... newly released paper, "The Role of Managed Care ... issues around gaps and barriers to addiction treatment ...
(Date:12/2/2016)... -- Boston Scientific Corporation (NYSE: BSX ) ... assets and capabilities of the Neovasc, Inc., (NASDAQ: ... as well as a 15% equity stake in Neovasc, ... Neovasc advanced biological tissue business makes elements used in ... System. * Upon completion of the transaction, the ...
Breaking Medicine Technology:
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... On Dec. ... the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who have ... (MPNs) by going above and beyond the standard of care, demonstrating leadership within the ...
(Date:12/2/2016)... ... ... Advanced Inc., a leading provider of travel therapy and travel nursing across ... Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served as Vice ... leadership experience to Advanced Inc. He began his career in finance at Ernst & ...
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... interview of two ostomy patients, standing as living proof that attitude and determination ... digestive diseases and issues that spike around the holidays. This campaign will offer ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... Health" in USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized ... fulfilling lives. “We are prolonging life 6 years in the last 3 decades,” ...
Breaking Medicine News(10 mins):